Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00022490
Status:
TERMINATED
Last Update Posted:
2016-01-07
First Post:
2001-08-10
Brief Title:
Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia
Sponsor:
Organization:
OHSU Knight Cancer Institute